R

Rallybio Corp
D

RLYB

0.50930
USD
-0.05
(-8.33%)
مغلق
حجم التداول
8,945
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
21,281,850
أصول ذات صلة الأخبار المقالات

العنوان: Rallybio Corp

القطاع: Healthcare
الصناعة: Biotechnology
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.